Anu Sebin

Anu Sebin is a Senior Scientist at Merck since October 2018, with a progressive career that began as a Junior Research Fellow at the National Centre for Biological Sciences in January 2010. Previous roles include Scientist II and Scientist at Merck, a Research Associate III at Genentech, and a Research Associate at Stem Cell Theranostics, where Anu focused on the characterization of patient-specific induced pluripotent stem cells. Experience at Stanford University School of Medicine included optimizing growth media for induced pluripotent stem cells and performing gene editing using the CRISPR-Cas9 system. Educational qualifications consist of a Bachelor of Technology in Biotechnology from Sathyabama University and a Master of Technology in Biotechnology from Vellore Institute of Technology.